Duramed (DRMD) Synthetic Estrogen Product Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: kevin kirkendall who started this subject	5/6/2001 10:43:42 AM
From: vestor	of 1837

IBD Stock Checkup Analysis: Duramed Pharmaceuticals receives an overall rating of B+, which is in the 85th percentile of all stocks in the Investor's Business Daily database. The overall rating is calculated using five proprietary ratings that measure each stock's Technical and Fundamental qualities and the Technical and Fundamental qualities of the industry group that it resides in, as well as a rating on the stock's current price attractiveness. Duramed Pharmaceuticals receives a Technical Rating of 93, which places it 3rd out of 14 stocks in the Medical-Generic Drugs group. Duramed Pharmaceuticals receives a Fundamental Rating of 73, which places it 9th out of 14 stocks in the Medical-Generic Drugs group. Duramed Pharmaceuticals receives an Attractiveness Rating of 87, placing it 5th out of 14 stocks in its group. The Medical-Generic Drugs group's technical rating of D- ranks it in the 36th percentile of the 197 different Investor's Business Daily Industry Groups. The Medical-Generic Drugs group's fundamental rating is C+, ranking it in the 74th percentile of all groups.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next